Gary Fischer was named vice president and chief financialofficer at Shaman Pharmaceuticals Inc. of San Carlos, Calif.Fischer was chief financial officer at Synergy SemiconductorCorp.
MedImmune Inc. of Gaithersburg, Md., named Michael D.Kishbauch executive vice president. Kishbauch was vicepresident, product planning and promotion at Ciba-Geigy.
Richard Dixon was named vice president of research at TexasBiotechnology Corp. of Houston. He was scientific director.
U.S. Bioscience of West Conshohocken, Pa., named WolfgangOster vice president for international clinical research, medicaland regulatory affairs. Oster was head of clinical research inoncology at Behringwerke, a division of Hoechst AG.
Metra Biosystems of Palo Alto, Calif., named Leonard D.Schaeffer, chairman and chief executive officer of Blue Cross ofCalifornia, to the company's board of directors.
Steven G. Einstein was named associate director, newtechnologies/MR applications at Bio-Imaging Technologies Inc.of West Trenton, N.J.
The Pennsylvania Biotechnology Association named Richard D.Gill vice president. He is vice president of agribusiness and foodat British Technology Group USA.
George M. Gibson was named to the board of directors ofEnzymatics Inc. of Horsham, Pa. Gibson recently retired as vicepresident and treasurer of Procter & Gamble Co.
Tularik Inc. of South San Francisco, Calif., named Andrew J.Perlman vice president of medical research. Perlman wassenior director of clinical research at Genentech Inc.
Glenn Prestwich, director of th Center for Biotechnology, waselected to the board of directors of the New York BiotechnologyAssociation.
William G. Pietersen was named executive vice president andpresident, of Sterling Winthrop Inc.'s consumer health group.Pietersen held several positions at Joseph E. Seagram & SonsInc.
(c) 1997 American Health Consultants. All rights reserved.